Delivery Order SPE2DR25D9353-SPE2DR26FQWT2
Award Date 3/2/26
Potential Completion Date 3/23/26
Potential Value $2.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $5,127.05 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for OZURDEX 0.7 mg implants under its Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order has a firm fixed price and an ultimate completion date of March 27, 2026. The parent PPV-G GEN V contract,...
- The Defense Logistics Agency awarded a $4,101.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for OZURDEX 0.7 mg implants, effective January 21, 2026, with an ultimate completion date of February 11, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,016.14 to DMS Pharmaceutical Group Inc. on September 10, 2025, for the supply of Ozurdex 0.7 mg implants. This firm fixed-price delivery order, which carries an ultimate completion date of October 1, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The delivery order does not utilize a set-aside designation and will be performed at the contractor's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,010.76 for OZURDEX 0.7 mg implants on June 18, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The contract carries no set-aside designation...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,003.02 contract is for the supply of Ozurdex 0.7 mg implants, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $3,004.53, is for the delivery of OZURDEX 0.7 MG IMPLANTS with a completion date of March 12, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,004.53, is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the recurring pharmaceutical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical's indefinite delivery contract for $2,925.87 to supply 0.7 mg OZURDEX implants. The delivery order has a completion date of December 21, 2023 and was awarded on November 30, 2023. No set-aside designation was used for this award. DMS Pharmaceutical Group will fulfill the delivery order from its location in Park Ridge, Illinois as a woman-owned small business...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,021.52 for OZURDEX 0.7 mg implants on September 19, 2025. The delivery order, which is not subject to any set-aside designation, is expected to be completed by October 10, 2025, and will be performed at the vendor's Park Ridge location. This award is issued under the company's larger Indefinite Delivery Contract with the...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $2,925.87 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 0.7 mg OZURDEX implants. The contract has a period of performance from August 1, 2023 through August 22, 2023, with all work to be performed by DMS Pharmaceutical Group Inc. at its facility located in Park Ridge, Illinois. No additional details were provided regarding the original solicitation or whether this...